Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O76061
UPID:
STC2_HUMAN
Alternative names:
Stanniocalcin-related protein
Alternative UPACC:
O76061
Background:
Stanniocalcin-2, also known as Stanniocalcin-related protein, plays a crucial role in calcium and phosphate homeostasis, exhibiting an anti-hypocalcemic action. This protein's unique function in regulating mineral balance underscores its importance in physiological processes.
Therapeutic significance:
Understanding the role of Stanniocalcin-2 could open doors to potential therapeutic strategies. Its pivotal role in mineral regulation presents an opportunity for developing treatments targeting metabolic disorders.